Skip to content

ACS Community Access to Resources Education and Support

Community Engagement in the Development of Oncology Navigation Training

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06285929
Acronym
ACS CARES
Enrollment
2000
Registered
2024-02-29
Start date
2023-09-01
Completion date
2025-12-31
Last updated
2024-02-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neoplasms

Keywords

Patient Navigation, Patient Satisfaction, Patient Engagement, Patient Empowerment, Patient Participation, Treatment Adherance

Brief summary

The goal of this study is to evaluate the pilot phase of ACS Cares to identify key implementation outcomes and assess effectiveness of the program to improve distress, enhance communication, and reduce missed appointments and healthcare utilization.

Detailed description

In 2023, the American Cancer Society (ACS) created a new program, ACS Cares, based on the Take the Fight experience and existing literature on non-clinical navigation. The goal of ACS Cares is to supplement existing navigation infrastructure to extend navigation services to a broader population of patients. This is accomplished through designating lower level, timely tasks to volunteers and allowing paid navigators to practice at the highest level of their license (e.g nurses proving symptom management, higher level coordination). The goal of this study is to evaluate the pilot phase of ACS Cares to identify key implementation outcomes and assess effectiveness of the program to improve distress, enhance communication, and reduce missed appointments and healthcare utilization.

Interventions

OTHERACS CARES Student Navigation

Student volunteers providing navigation support to patients, families and caregivers with a cancer diagnosis through an SDOH assessment.

Sponsors

University of Alabama at Birmingham
CollaboratorOTHER
American Cancer Society, Inc.
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* patients of health system's healthcare physician champions with a confirmed cancer diagnosis * patients with a confirmed cancer diagnosis * families of patients with a confirmed cancer diagnosis * Caregivers of patients with a confirmed cancer diagnosis

Exclusion criteria

* patients, families and/or caregivers without a confirmed cancer diagnosis * patients not receiving care from healthcare physician champions

Design outcomes

Primary

MeasureTime frameDescription
Context, Training, and Process Measures: Service Penetrance and Process Measures: Service Penetrancethrough study completion, an average of 1 year• # of patients/caregivers approached for ACS CARES Median and range per volunteer • # of patients/caregivers who decline by refusal reason • # of patients/caregivers supported by ACS CARES Median and range per volunteer • # of patients/caregivers who received psychosocial distress screening Median and range per ACS CARES volunteer • # of patients/caregivers who received an SDOH screening Median and range per ACS CARES volunteer • # of follow-ups conducted Median and range per ACS CARES volunteer • # of in-person visits conducted Median and range per ACS CARES volunteer • # of shifts completed Median and range per ACS CARES volunteer • # of referrals received from health system team members
Measure the impact of ACS CARES on patient-reported outcomes: Patient activationBaseline and 6 months into pilotPatient activation
Measure the impact of ACS CARES on patient-reported outcomes: Financial toxicityBaseline and 6 months into pilotFinancial toxicity
Measure the impact of ACS CARES on patient-reported outcomes: Quality of lifeBaseline and 6 months into pilotQuality of life
Measure the impact of ACS CARES on patient-reported outcomes: SDOH barriersBaseline and 6 months into pilotSDOH barriers
Measure the impact of ACS CARES on patient-reported outcomes: Information NeedsBaseline and 6 months into pilotInformation Needs
Measure the impact of ACS CARES on patient-reported outcomes: Distress needsBaseline and 6 months into pilotDistress needs
Measure the impact of ACS CARES on patient-reported outcomes: Satisfaction with programBaseline and 6 months into pilotSatisfaction with program
Measure the impact of ACS CARES on patient-reported outcomes: Unmet needsBaseline and 6 months into pilotUnmet needs
Measure the impact of ACS CARES on patient-reported outcomes: Patient-provider communicationBaseline and 6 months into pilotPatient-provider communication
Measure the impact of ACS CARES on patient-reported outcomes: clinical trials knowledgeBaseline and 6 months into pilotclinical trials knowledge

Secondary

MeasureTime frameDescription
Impact of ACS CARES on treatment adherence and healthcarebaseline and 1 yearCancer and treatment characteristics: cancer type, date of diagnosis, type of current treatment (Surgery, Chemotherapy, Radiation Therapy, Targeted Therapy, Immunotherapy, Stem Cell or Bone Marrow Transplant, Hormone Therapy), total clinic appointments, # clinic appts missed/cancelled, total infusion appointments, # infusion appointments missed/cancelled, total radiation treatment appts, # radiation treatment appointments missed/cancelled, enrolled in a clinical trial (y/n), start date of clinical trial participation, ER visits, hospitalizations, ICU admissions, total cost of care. For new patients during baseline or intervention time periods, date of first clinic visit.
Context, Training, and Process Measures: Volunteer Satisfaction1 yearVolunteer Satisfaction Index
Sociodemographic differences between ACS CARES supported and non-ACS CAREs supported patientsbaseline and 1 yearPatient characteristics: age, sex, gender (if available), race, ethnicity, insurance status, zip code, urban or rural residence, Area Deprivation Index category, and distance from cancer center (\<30 minutes, 30-60 minutes, \>60 minutes)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026